newsfilter
← Latest News
GlobeNewswire·

Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell